Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · Real-Time Price · USD
1.090
0.00 (0.01%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Eyenovia Revenue
In the year 2024, Eyenovia had annual revenue of $57.34K with 1,414.02% growth. Eyenovia had revenue of $28.09K in the quarter ending December 31, 2024, with 985.09% growth.
Revenue (ttm)
$57.34K
Revenue Growth
+1,414.02%
P/S Ratio
15.84
Revenue / Employee
$4,095
Employees
14
Market Cap
3.09M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
EYEN News
- 14 days ago - Eyenovia Provides Development Update on Optejet User Filled Device (UFD) - GlobeNewsWire
- 5 weeks ago - Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - GlobeNewsWire
- 2 months ago - Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements - GlobeNewsWire
- 2 months ago - Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives - GlobeNewsWire
- 2 months ago - Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - GlobeNewsWire
- 3 months ago - Eyenovia Announces 1-for-80 Reverse Stock Split - GlobeNewsWire
- 3 months ago - Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - GlobeNewsWire
- 3 months ago - Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives - GlobeNewsWire